Maxcyte (MXCT) Gross Margin (QoQ) (2020 - 2026)
Maxcyte (MXCT) Gross Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Maxcyte | 146.35 Mn | 146.35 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -678.00 |
| Mar 31, 2026 | 29,887.00 |
| Dec 31, 2025 | -19,594.00 |
| Sep 30, 2025 | -552.00 |
| Jun 30, 2025 | -345.00 |
| Mar 31, 2025 | -2,030.00 |
| Dec 31, 2024 | 2,951.00 |
| Sep 30, 2024 | -10,373.00 |
| Jun 30, 2024 | 213.00 |
| Mar 31, 2024 | 12,491.00 |
| Dec 31, 2023 | -12,042.00 |
| Sep 30, 2023 | 8,872.00 |
| Jun 30, 2023 | -6,784.00 |
| Mar 31, 2023 | 1,238.00 |
| Dec 31, 2022 | 5,310.00 |
| Sep 30, 2022 | -120.00 |
| Jun 30, 2022 | -249.00 |
| Mar 31, 2022 | -2,810.00 |
| Dec 31, 2021 | 2,824.00 |
| Sep 30, 2021 | 173.00 |